MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
WALD stock logo

WALD

Waldencast plc

$1.66
0.02
 (1.22%)
Exchange:  NASDAQ
Market Cap:  196.278M
Shares Outstanding:  11.678M
Delayed data
Calculate WALD Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Technology
Industry:  Software – Application
   
CEO:  Michel Brousset
Full Time Employees:  335
Address: 
10 Bank Street
White Plains
NY
10606
US
Website:  http://www.waldencast.com
Waldencast plc operates as a specialized skincare enterprise, delivering sophisticated treatments aimed at improving various dermatological conditions. Its product offerings are crafted to minimize the visual impact of early aging, skin damage, uneven pigmentation, acne, and harm from sun exposure. These solutions are predominantly distributed through professional avenues such as dermatologists, plastic surgeons, medical spas, and other skincare professionals. The company’s portfolio encompasses Obagi Medical, which provides groundbreaking skincare products designed to alleviate signs of skin aging, treat issues like dark spots, hyperpigmentation, and fine lines, while simultaneously protecting and enhancing skin’s overall tone and texture. Additionally, its Obagi Clinical line features products specifically developed to stave off the initial indicators of skin aging. Founded in 1988, Waldencast plc is based in White Plains, New York.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/14 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue218,138273,868272,071
Gross Profit141,577131,729123,834
EBITDA-33,53928,632-2,491
Operating Income-81,931-58,584-61,675
Net Income-89,981-42,443-229,749

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets1,090,0751,042,710975,860
Total Liabilities290,177273,437245,923
Total Stockholders Equity639,239624,626662,319
Total Debt199,247177,724182,106
Cash and Cash Equivalents8,69322,57614,802

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-85,014-29,775-8,820
Capital Expenditure-2,496-2,045.999-3,012
Free Cash Flow-87,510-31,820.999-11,832
Net Income-116,624-89,981-48,648
Net Change in Cash-3,28112,413-6,274

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2027Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)304,397.978Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)307,600.010Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)306,442.325Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-33,845.379Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-33,493.058Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-33,717.998Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)-66,718.534Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)-65,816.238Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)-66,267.386Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)228,182.818Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)230,583.125Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)229,715.301Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)-0.580Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)-0.580Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)-0.580Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
273.868M  ?P/S
 (TTM)
: 
0.75
?Net Income
 (TTM)
: 
-42443000  ?P/E
 (TTM)
: 
-0.89
?Enterprise Value
 (TTM)
: 
320.492M  ?EV/FCF
 (TTM)
: 
-19.73
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.48  ?ROIC
 (TTM)
: 
-0.08
?Net Debt
 (TTM)
: 
165.804M  ?Debt/Equity
 (TTM)
: 
0.32
?P/B
 (TTM)
: 
0.44  ?Current Ratio
 (TTM)
: 
1.7

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about WALD valuation

Is Waldencast plc (WALD) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Waldencast plc (WALD) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is WALD a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether WALD trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is WALD’s P/E ratio?

You can see WALD’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for WALD?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is WALD a good long-term investment?

Whether WALD fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

WALD

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.22
MARKETSnap

Trading Metrics:

Open: 1.64   Previous Close: 1.64
Day Low: 1.63   Day High: 1.71
Year Low: 0.72   Year High: 3.22
Price Avg 50: 1.21   Price Avg 200: 1.68
Volume: 136940   Average Volume: 1.398M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
11-03-2026 16:05
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
27-02-2026 08:33
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of “Moderate Buy” from Analysts
16-02-2026 03:33
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of “Moderate Buy” from Analysts
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
03-02-2026 09:39
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read